MEDXF - Medexus Pharmaceuticals' (MEDXF) CEO Ken d'Entremont on Q1 2022 Results - Earnings Call Transcript
Medexus Pharmaceuticals, Inc. (MEDXF) Q1 2022 Earnings Conference Call August 17, 2021 8:00 AM ET Company Participants Tina Byers – Investor Relations Ken d’Entremont – Chief Executive Officer Marcel Konrad – Chief Financial Officer Conference Call Participants Justin Keywood – Stifel GMP Prasath Pandurangan – Bloom Burton Securities Presentation Operator Good day, ladies and gentlemen, and welcome to the Medexus Pharmaceuticals' First Quarter Fiscal 2022 Earnings Call. All lines have been placed on a listen-only mode, and the floor will be open for questions and comments following the presentation. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host, Tina Byers. Ma'am, the floor is yours. Tina Byers Thank you and good morning, everyone. Welcome to the Medexus Pharmaceuticals first quarter fiscal 2022 earnings call. On the call this morning are Ken d’Entremont, Chief Executive Officer; and Marcel Konrad, Chief Financial Officer. If
For further details see:
Medexus Pharmaceuticals' (MEDXF) CEO Ken d'Entremont on Q1 2022 Results - Earnings Call Transcript